Estimating the effect of regression to the mean in health management programs

Disease Management and Health Outcomes

Volumn 15, Issue 1, 2007, Pages 7-12

  Linden, Ariel ^a,b  

^a LINDEN CONSULTING GROUP   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEALTH CARE MANAGEMENT; HEALTH PROGRAM; OUTCOME ASSESSMENT; REGRESSION ANALYSIS; REVIEW;

EID: 33947218784     PISSN: 11738790     EISSN: None     Source Type: Journal    
DOI: 10.2165/00115677-200715010-00002     Document Type: Review

References (40)

1. Galton F. Regression towards mediocrity in hereditary stature. J Anthropol Inst 1886; 15: 246-63
2. Stigler SM. Regression towards the mean, historically considered. Stat Methods Med Res 1997; 6 (2): 103-14
3. Gardner MJ, Hardy JA. Some effects of within person variability in epidemiological studies. J Chronic Dis 1973; 26: 781-95
4. Johnson WD, George VT. Effect of regression to the mean in the presence of within-subject variability. Stat Med 1991; 10: 1295-302
5. Boissel JP, Duperat B, Leizorowicz A. The phenomenon of regression to the mean and clinical investigation of blood cholesterol lowering drugs. Eur J Clin Pharmacol 1980; 17: 227-30
6. Andrews G, Harvey R. Regression to the mean in pretreatment measures of stuttering. J Speech Hear Disord 1981; 46: 204-7
7. Shepard DS, Finison LJ. Blood pressure reductions: correcting for regression to the mean. Prev Med 1983; 12: 304-17
8. Denke MA, Frantz ID. Responses to a cholesterol-lowering diet: efficacy is greater in hypercholesterolemic subjects even after adjustment for regression to the mean. Am J Med 1993; 94: 626-31
9. Herpin D, Demange J. Effect of regression to the mean in serial echocardiographic measurements of left ventricular mass: quantification and clinical implications. Am J Hypertens 1994; 7: 824-8
10. Forrow L, Calkins DR, Allshouse K, et al. Evaluating cholesterol screening: the importance of controlling for regression to the mean. Arch Intern Med 1995; 155: 2177-84
11. Prescott RJ, Garraway WM. Regression to the mean occurs in measuring peak urinary flow. Br J Urol 1995; 76: 611-3
12. Pitts SR, Adams RP. Emergency department hypertension and regression to the mean. Ann Emerg Med 1998; 31: 214-8
13. Murakawa Y, Yamashita T, Ajiki K, et al. Ostensible day-night difference of QT prolongation during long-term treatment with antiarrhythmic drugs: reappraisal of the law of 'regression to the mean'. J Cardiovasc Pharmacol 1998; 32: 62-5
14. Cummings SR, Palermo L, Browner W, et al. Monitoring osteoporosis therapy with bone densitometry: misleading changes and regression to the mean. JAMA 2000; 283: 1318-21
15. Asmar R, Safar M, Oueneau P. Evaluation of the placebo effect and reproducibility of blood pressure measurement in hypertension. Am J Hypertens 2001; 14 (6 Pt 1): 546-52
16. Takashima Y, Sumiya Y, Kokaze A, et al. Magnitude of the regression to the mean within one-year intra-individual changes in serum lipid levels among Japanese male workers. J Epidemiol 2001; 11: 61-9
17. Linden A, Adams J, Roberts N. An assessment of the total population approach for evaluating disease management program effectiveness. Dis Manage 2003; 6 (2): 93-102
18. Ware Jr JE, Kosinski M, et al. A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996; 34: 220-33
19. Butterworth S, Linden A, McClay M, et al. The effect of motivational interview ing-based health coaching on employees' physical and mental health status. J Occup Healt Psych 2006; 11 (4): 358-65
20. Ware JE, Losinski M, Turner-Bowker DM, et al. How to score Version 2 of the SF-12. health survey (with a Suppl. documenting Version 1). Lincoln (RI): QualityMetric Incorporated, 2002
21. Davis CE. The effect of regression to the mean in epidemiologic and clinical studies. Am J Epidemiol 1976; 104: 493-8
22. Blomqvist N, Cederblad G, Korsan-Bengtsen K, et al. Application of a method for correcting an observed regression between change and initial value for the bias caused by random errors in the initial value. Clin Chem 1977; 23 (10): 1845-8
23. Senn SJ, Brown RA. Estimating treatment effects in clinical trials subject to regression to the mean. Biometrics 1985; 41: 555-60
24. Curnow RN. Correcting for regression in assessing the response to treatment in a selected population. Stat Med 1987; 6: 113-7
25. Senn S. Regression to the mean and crossover trials revisited. Stat Med 1994; 13: 1181-6
26. Hannan PJ, Jacobs Jr DR, McGovern P, et al. Estimating the effect of regression toward the mean under stochastic censoring. Am J Epidemiol 1994; 139 (4): 422-31
27. Ross DC. Using severity rather than randomization for assignment in clinical trials: Monte Carlo tests and practical illustrations of the Robbins-Zhang method. J Psychiatr Res 1995; 29: 315-32
28. Chuang-Stein C, Tong DM. The impact and the implication of regression to the mean on the design and analysis of medical investigations. Stat Methods Med Res 1997; 6: 115-28
29. Chesher A. Non-normal variation and regression to the mean. Stat Methods Med Res 1997; 6: 147-66
30. Copas JB. Using regression models for prediction: shrinkage and regression to the mean. Stat Methods Med Res 1997; 6: 167-83
31. Chen S, Cox C, Cui L. A more flexible regression-to-the-mean model with possible stratification. Biometrics 1998; 54: 939-47
32. Trochim WMK. The research methods knowledge base. 2nd ed. Cincinnati (OH): Atomic Dog Publishing, 2001
33. Muller HG, Abramson I, Azari R. Nonparametric regression to the mean. Proc Nat Acad Sci 2003; 100 (17): 9715-20
34. Tu YK, Baelum V, Gilthorpe MS. The relationship between baseline value and its change: problems in categorization and the proposal of a new method. Eur J Oral Sci 2005; 113 (4): 279-88
35. Rosenthal R. An application of the Kolmogorov-Smirnov test for normality with estimated mean and variance. Psychol Rep 1968; 22: 570
36. Linden A, Adams J, Roberts N. Evaluating disease management program effectiveness: an introduction to the regression-discontinuity design. J Eval Clin Pract 2006; 12 (2): 124-31
37. Barnett AG, van der Pols JC, Dobson AJ. Regression to the mean: what it is and how to deal with it. Int J Epidemiol 2005; 34: 215-20
38. Klepp K-I, Ulvik RJ, Matthiesen SB, et al. Cholesterol screening: observed cholesterol reduction in a prospective study in Norway. Eur J Publ Hlth 1993; 3: 38-42
39. Marquis MS, Buntin MB, Escarce JJ, et al. Is the individual market more than a bridge market? An analysis of disenrollment decisions. Inquiry 2005/2006 Winter; 42 (4): 381-96
40. California HealthCare Foundation. 2005 snapshot: individual health insurance market [online]. Available from URL: http: //www.chcf.org/documents/ insurance/SnapshotIndividualMarket05.pdf [Accessed 2006 Nov 24]